The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Ipratropium ID: ALA3085123
PubChem CID: 9969258
Max Phase: Preclinical
Molecular Formula: C20H30ClNO3
Molecular Weight: 332.46
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2.[Cl-]
Standard InChI: InChI=1S/C20H30NO3.ClH/c1-14(2)21(3)16-9-10-17(21)12-18(11-16)24-20(23)19(13-22)15-7-5-4-6-8-15;/h4-8,14,16-19,22H,9-13H2,1-3H3;1H/q+1;/p-1/t16-,17+,18+,19?,21?;
Standard InChI Key: MQIPRYDNKGFOGV-WDTICOSOSA-M
Molfile:
RDKit 2D
27 28 0 0 0 0 0 0 0 0999 V2000
12.1770 2.6099 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.9388 1.8966 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4123 0.4653 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1376 4.5666 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.6982 4.1267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2773 3.7535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2277 5.3866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7652 3.3248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6270 4.1422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2490 3.7535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3777 3.4181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7574 3.0412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3732 4.8770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7638 1.8958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1756 1.1809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5625 5.8747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9829 5.7186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7623 0.4669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0006 1.1801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1741 -0.2480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9373 0.4677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7609 -0.9621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5241 -0.2464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9359 -0.9612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7303 2.8620 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
11.2474 3.2910 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
8.0437 1.0607 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
8 1 1 6
1 14 1 0
2 14 2 0
3 19 1 0
4 5 1 0
4 6 1 0
4 7 1 0
4 13 1 0
5 9 1 0
5 11 1 0
6 10 1 0
6 12 1 0
7 16 1 0
7 17 1 0
8 9 1 0
8 10 1 0
11 12 1 0
14 15 1 0
15 18 1 0
15 19 1 0
18 20 2 0
18 21 1 0
20 22 1 0
21 23 2 0
22 24 2 0
23 24 1 0
6 25 1 1
5 26 1 6
M CHG 2 4 1 27 -1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 332.46Molecular Weight (Monoisotopic): 332.2220AlogP: 2.85#Rotatable Bonds: 5Polar Surface Area: 46.53Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: -1.82CX LogD: -1.82Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.67Np Likeness Score: 0.73
References 1. Santana L, González-Díaz H, Quezada E, Uriarte E, Yáñez M, Viña D, Orallo F.. (2008) Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors., 51 (21): [PMID:18834112 ] [10.1021/jm800656v ] 2. Ahlin G, Karlsson J, Pedersen JM, Gustavsson L, Larsson R, Matsson P, Norinder U, Bergström CA, Artursson P.. (2008) Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1., 51 (19): [PMID:18788725 ] [10.1021/jm8003152 ]